UK Appeals Court Sends Singulair Arguments To EU Court

Law360, New York (April 18, 2013, 5:33 PM EDT) -- Sigma Pharmaceuticals PLC's appeal of a ruling that it violated European patent laws by importing Merck & Co. Inc.’s asthma drug Singulair from Poland to the U.K. cannot be decided until the Court of Justice interprets parts of EU law central to the dispute, a U.K. court said Thursday.

The England and Wales Court of Appeal said the bloc's Court of Justice would have to interpret parts of the 2003 Act of Accession of Poland into the European Union to determine if an April 2012 ruling...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.